Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA ...

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developi ...

Zion Wood, a young boy from Mahwah living with severe autism, recently experienced a dream trip to the Central Florida theme ...

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today ...

"This artificial intelligence technique can be applied not only to Hall thrusters but also to the research and development of ion beam sources used in various industries, including semiconductors, ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Novartis issued stronger guidance than Wall Street expected. Elsewhere, Eisai and Biogen’s Alzheimer’s drug will get a closer ...

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

Researchers find blocking the KCNB2 gene can slow tumor growth, paving the way for next-gen treatments for childhood brain cancer.

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

New York City firefighters encountered a frozen hydrant, as well as multiple e-bikes and lithium-ion batteries, following a Friday morning fire in Queens, the FDNY said. Elizabeth Warren tells Elon ...

While it may not sound like a major leap, this approach offers one big advantage: killing cancerous cells while doing less ...